Literature DB >> 24294392

Post cardiac transplantation T-cell lymphoproliferative disorder presenting as a solitary lung nodule.

Barina Aqil1, Bhuvaneswari Krishnan, Choladda V Curry, M Tarek Elghetany, Reka Szigeti.   

Abstract

Post-transplantation lymphoproliferative disorder (PTLD) is an infrequent, but serious complication of solid organ and bone marrow transplantations. The vast majority of the cases are of B-cell origin and usually associated with Epstein-Barr virus (EBV) infection. The non-B (T and NK cell) PTLDs account for up to 14% of the PTLD cases in Western countries. We report a case of a 66-year-old man who received an orthotopic heart transplant for cardiomyopathy 7 years prior to presentation. He was referred to our institution with a hypermetabolic solitary right lower lobe lung nodule with an SUV of 9.2 on PET scan. The combined histomorphological and immunohistochemical pattern was most consistent with monomorphic PTLD, peripheral T-cell lymphoma with angioimmunoblastic features. Molecular studies showed clonal T-cell gamma receptor gene rearrangement. Primary pulmonary involvement of T-cell PTLD is extremely rare. This is the third reported case of T-cell PTLD after cardiac transplantation, primarily involving the lung. Further, studies will be required to determine the appropriate treatment and prognosis of this rare entity.

Entities:  

Keywords:  PTLD; T-cell lymphoma; heart transplantation; lung nodule

Mesh:

Substances:

Year:  2013        PMID: 24294392      PMCID: PMC3843286     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

Review 1.  Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant.

Authors:  Jason Haldas; Wei Wang; John Lazarchick
Journal:  Leuk Lymphoma       Date:  2002-02

2.  Lymphoproliferative disorders in renal transplant patients in Japan.

Authors:  Y Hoshida; T Li; Z Dong; Y Tomita; A Yamauchi; J Hanai; K Aozasa
Journal:  Int J Cancer       Date:  2001-03-15       Impact factor: 7.396

3.  Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

Authors:  B P Nelson; M A Nalesnik; D W Bahler; J Locker; J J Fung; S H Swerdlow
Journal:  Am J Surg Pathol       Date:  2000-03       Impact factor: 6.394

4.  Characterization of posttransplant lymphomas that express T-cell-associated markers: immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice.

Authors:  E K Waller; M Ziemianska; C D Bangs; M Cleary; I Weissman; O W Kamel
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

Review 5.  Posttransplant T-cell lymphoma. Report of three cases and a review of the literature.

Authors:  J van Gorp; H Doornewaard; L F Verdonck; C Klöpping; P F Vos; J G van den Tweel
Journal:  Cancer       Date:  1994-06-15       Impact factor: 6.860

6.  Lymphomas after solid organ transplantation: a collaborative transplant study report.

Authors:  Gerhard Opelz; Bernd Döhler
Journal:  Am J Transplant       Date:  2004-02       Impact factor: 8.086

Review 7.  T-cell posttransplant lymphoproliferative disorder occurring in a pediatric solid-organ transplant patient.

Authors:  Ryan Lundell; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

Review 8.  Post transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature.

Authors:  Ravindra Rajakariar; Madhumita Bhattacharyya; Andrew Norton; Michael Sheaff; Jamie Cavenagh; Martin J Raftery; Muhammad M Yaqoob
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

9.  Chronic antigenic stimulation from the graft as a possible oncogenic factor after renal transplant.

Authors:  S A Birkeland
Journal:  Scand J Urol Nephrol       Date:  1983

10.  Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients.

Authors:  G Opelz; R Henderson
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.